Drug Information Association Logo

Publications in a Brave New World

Track:
Medical Writing Publication Topics

Day & Time:
March 12, 1:00PM - 2:30PM

Room Number:
Ballroom Salon I

Type:
Session

Title:
Publications in a Brave New World

Chair(s):
Chad Wagner, PharmD
Director, Consumer Experience and Digital Channels
Eli Lilly & Company, United States

Description:
Health care professionals (HCP's) have more options than ever when seeking scientific information. While traditional sources of information are still relevant, new sources are proliferating. These new sources are predominantly digital in nature and are forcing us to re-evaluate how we create and share scientific information. In this session we will take a deeper look at the digital behaviors of HCP's and how those behaviors are causing change with traditional publishers. We will also examine the emergence of non-traditional publishers and how they are disrupting how information is delivered.

Learning Objective(s):
At the conclusion of this session, participants should be able to:
Discuss the HCP behaviors in digital channels when seeking scientific content
Identify how to better tailor content to align with customer behaviors, how to place that content in relevant places, and how to measure the impact
Discuss how traditional publishers are adapting and evolving, and how new forms of access are emerging
Describe emerging tactics to measure relevance of publications in a digital world

Presentation(s) & Speaker(s):
Publications in a “Brave New World”
Chad Wagner, PharmD
Director, Consumer Experience and Digital Channels
Eli Lilly & Company, United States

Faculty
James Avallone
Director, Physician Research
Manhattan Research, Decision Resources Group, United States

© 2014 DIA